These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19718985)

  • 1. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
    Debre P; Costagliola D; Legrand R; Vieillard V
    Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques.
    Vieillard V; Habib RE; Brochard P; Delache B; Bovendo HF; Calvo J; Morin J; Picq I; Martinon F; Vaslin B; Le Grand R; Debré P
    AIDS; 2008 Jan; 22(2):185-92. PubMed ID: 18097220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.
    Vieillard V; Strominger JL; Debré P
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10981-6. PubMed ID: 16046540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques.
    Vieillard V; Dereuddre-Bosquet N; Mangeot-Méderlé I; Le Grand R; Debré P
    Vaccine; 2012 Nov; 30(48):6883-91. PubMed ID: 22989687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
    Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
    Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques.
    Vieillard V; Le Grand R; Dausset J; Debré P
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2100-4. PubMed ID: 18234855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
    Curriu M; Fausther-Bovendo H; Pernas M; Massanella M; Carrillo J; Cabrera C; López-Galíndez C; Clotet B; Debré P; Vieillard V; Blanco J
    PLoS One; 2012; 7(2):e30330. PubMed ID: 22312424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
    Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
    J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.
    Fausther-Bovendo H; Vieillard V; Sagan S; Bismuth G; Debré P
    PLoS Pathog; 2010 Jul; 6(7):e1000975. PubMed ID: 20617170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
    Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
    J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
    Massanella M; Puigdomènech I; Cabrera C; Fernandez-Figueras MT; Aucher A; Gaibelet G; Hudrisier D; García E; Bofill M; Clotet B; Blanco J
    AIDS; 2009 Jan; 23(2):183-8. PubMed ID: 19098487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapy.
    Sennepin A; Baychelier F; Guihot A; Nel I; Ho Tsong Fang R; Calin R; Katlama C; Simon A; Crouzet J; Debré P; Vieillard V
    AIDS; 2013 Jul; 27(12):1857-66. PubMed ID: 24179999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of CD40 ligand in HIV infection.
    Kornbluth RS
    J Leukoc Biol; 2000 Sep; 68(3):373-82. PubMed ID: 10985254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
    Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
    Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 infection: functional competition between gp41 and interleukin-2.
    Sanhadji K; Tardy JC; Touraine JL
    C R Biol; 2010 Aug; 333(8):608-12. PubMed ID: 20688281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.
    Rutjens E; Vermeulen J; Verstrepen B; Hofman S; Prins JM; Srivastava I; Heeney JL; Koopman G
    Eur J Immunol; 2008 Apr; 38(4):1164-72. PubMed ID: 18383039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.